Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PedTac population pharmacokinetics of tacrolimus in pediatric solid organ transplant recipients
2013-000793-30Phase 4Terminated
- Sponsor
- Oslo University Hospital
- Start
- Jul 2013
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of tacrolimus in solid organ transplantation (SOT) and graft rejection, sponsored by Oslo University Hospital. Started Jul 2013; status: terminated.
02
Drugs
tacrolimus
03
Conditions
solid organ transplantation (SOT)graft rejection
Beyond the preview
Go deeper on 2013-000793-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000793-30.